Free Account Opening + AMC Free Demat
Loading...

Aakash Exploration IPO vs Indo US BioTech IPO

Comparision between Aakash Exploration IPO and Indo US BioTech IPO.

IPO Details

Aakash Exploration IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Indo US BioTech IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  Aakash Exploration IPO Indo US BioTech IPO
Logo Aakash Exploration IPO Logo Indo US BioTech IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At NSE SME BSE SME
Lead Managers Monarch Networth Capital Ltd Swastika Investmart Ltd
Registrar Skyline Financial Services Private Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Aakash Exploration IPO is up to ₹10.08 Cr whereas the issue size of the Indo US BioTech IPO is up to ₹7.29 Cr. The final issue price of Aakash Exploration IPO is ₹56.00 per share and of Indo US BioTech IPO is ₹51.00 per share.

  Aakash Exploration IPO Indo US BioTech IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹56.00 per share ₹51.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 2000 shares 2000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 18,00,000 shares 14,30,000 shares
Issue Size Total (Amount) up to ₹10.08 Cr up to ₹7.29 Cr

IPO Timetable

Aakash Exploration IPO opens on Apr 17, 2018, while Indo US BioTech IPO opens on Apr 30, 2018. The closing date of Aakash Exploration IPO and Indo US BioTech IPO is Apr 19, 2018, and May 03, 2018, respectively.

  Aakash Exploration IPO Indo US BioTech IPO
Anchor Bid Date
Issue Open Apr 17, 2018 Apr 30, 2018
Issue Close Apr 19, 2018 May 03, 2018
Basis Of Allotment (Tentative) Apr 24, 2018
Initiation of Refunds (Tentative) Apr 25, 2018
Credit of Share (Tentative) Apr 26, 2018
Listing date (Tentative) Apr 27, 2018
Anchor Lockin End date 1 May 24, 2018
Anchor Lockin End date 2 Jul 23, 2018

Financials

Aakash Exploration IPO P/E ratio is , as compared to Indo US BioTech IPO P/E ratio of .

  Aakash Exploration IPO Indo US BioTech IPO
Financial
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 3,382.38 3,131.06 2,549.24 1,393.22 1,056.70
Total Revenue 3,380.30 2,563.31 2,345.20 1,389.54 944.65
Profit After Tax 110.02 44.32 101.44 49.38 14.40
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 1,293.66 1,368.76 767.52 605.19 626.38
Total Revenue 2,457.79 1,914.53 1,966.07 1,485.50 1,493.84
Profit After Tax 64.99 35.99 49.59 25.96 29.94
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Aakash Exploration IPO retail investors (RII) are offered 8,55,000 shares while in Indo US BioTech IPO retail investors are offered 8,55,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Aakash Exploration IPO and 0 shares in Indo US BioTech IPO.

  Aakash Exploration IPO Indo US BioTech IPO
Anchor Investor Reserveration
Market Maker Reserveration 90,000 shares 74,000 shares
QIB 0 shares 0 shares
NII 8,55,000 shares 6,78,000 shares
RII 8,55,000 shares 6,78,000 shares
Employee
Others
Total 18,00,000 shares 14,30,000 shares

Bids Received (Subscription)

Aakash Exploration IPO subscribed 1.48x in total, whereas Indo US BioTech IPO subscribed 19.74x.

  Aakash Exploration IPO Indo US BioTech IPO
QIB (times)
NII (times) 1.59x 19.52x
Big NII (times)
Small NII (times)
RII (times) 1.38x 19.87x
Employee (times)
Other (times)
Total (times) 1.48x 19.74x

Comments

Add a public comment...